Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Boswellic acid, a potent antiinflammatory drug, inhibits rejection to the same extent as high dose steroids.

Dahmen U, Gu YL, Dirsch O, Fan LM, Li J, Shen K, Broelsch CE.

Transplant Proc. 2001 Feb-Mar;33(1-2):539-41. No abstract available.

PMID:
11266947
2.

Prolonged survival of murine cardiac allografts by treatment with the 4-amino analog of tetrahydrobiopterin.

Brandacher G, Zou Y, Obrist P, Steurer W, Werner-Felmayer G, Margreiter R, Werner ER.

Transplant Proc. 2001 Feb-Mar;33(1-2):516-7. No abstract available.

PMID:
11266933
3.

Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.

Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B, Ichim TE, Zhou D, Lian D, Kelvin DJ, Zhong R.

J Immunol. 2003 Oct 1;171(7):3823-36.

4.

Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.

Haeryfar SM, Lan Z, Leon-Ponte M, Duffy KR, Ge W, Liu W, Mele T, Garcia B, Wang H.

Transplantation. 2008 Aug 15;86(3):460-8. doi: 10.1097/TP.0b013e3181806b72.

PMID:
18698251
5.
6.

Pioglitazone prevents acute and chronic cardiac allograft rejection.

Kosuge H, Haraguchi G, Koga N, Maejima Y, Suzuki J, Isobe M.

Circulation. 2006 Jun 6;113(22):2613-22. Epub 2006 May 30.

7.

Prevention of chronic rejection in murine cardiac allografts: a comparison of chimerism- and nonchimerism-inducing costimulation blockade-based tolerance induction regimens.

Shirasugi N, Adams AB, Durham MM, Lukacher AE, Xu H, Rees P, Cowan SR, Williams MA, Pearson TC, Larsen CP.

J Immunol. 2002 Sep 1;169(5):2677-84.

8.

Tamoxifen prolongs heart allograft survival in cyclosporine-treated female mice.

Zou YP, Brandacher G, Obrist P, Margreiter R, Steurer W.

Transplant Proc. 1999 Feb-Mar;31(1-2):1222-3. No abstract available.

PMID:
10083546
9.

Comparative efficacy of liposomal FK506 with FK506.

Moffatt SD, McAlister V, Calne RY, Metcalfe S.

Transplant Proc. 1998 Dec;30(8):4066-7. No abstract available.

PMID:
9865297
10.
11.

C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A.

Jordan JL, Hirsch GM, Lee TD.

Transpl Immunol. 2008 Jul;19(3-4):159-66. doi: 10.1016/j.trim.2008.05.010. Epub 2008 Jul 9.

PMID:
18619544
12.

LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival.

Pietersz GA, Sandrin MS, Ling S, Li YQ, McKenzie IFC.

Transpl Immunol. 2001 Oct;9(1):7-11.

PMID:
11680574
13.

LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.

Zhou D, O'Brien C, Shum J, Garcia B, Min W, Jevnikar AM, Dutartre P, Zhong R.

Transplantation. 2003 Aug 27;76(4):644-50.

PMID:
12973102
14.

Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.

Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, Pagnotta M, Trucco M, Vassalli G.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3415-23. Epub 2007 Oct 12.

15.

Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.

Pieper GM, Nilakantan V, Chen M, Zhou J, Khanna AK, Henderson JD Jr, Johnson CP, Roza AM, Szabó C.

J Pharmacol Exp Ther. 2005 Jul;314(1):53-60. Epub 2005 Mar 22. Erratum in: J Pharmacol Exp Ther. 2006 Apr;317(1):462.

16.

Blockade of the OX40 ligand prolongs corneal allograft survival.

Hattori T, Usui Y, Okunuki Y, Sonoda Y, Usui M, Takada E, Mizuguchi J, Yagita H, Okumura K, Akiba H, Takeuchi M.

Eur J Immunol. 2007 Dec;37(12):3597-604.

17.

Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice.

Yan S, Zhang QY, Zhou B, Xue L, Chen H, Wang Y, Zheng SS.

Transplant Proc. 2009 Jun;41(5):1855-8. doi: 10.1016/j.transproceed.2009.02.073.

PMID:
19545743
18.

KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.

Circulation. 2005 Jan 18;111(2):222-9. Epub 2005 Jan 10.

19.

Prolonged survival of heart allografts transduced with AAV-CTLA4Ig.

Chen Z, Lu L, Li J, Xiao X, Fung JJ, Qian S.

Microsurgery. 2003;23(5):489-93.

PMID:
14558008
20.

Use of brequinar sodium for preventing cardiac allograft rejection in primates.

Makowka L, Tixier D, Chaux A, Hill D, O'Neill P, Eiras-Hreha G, Wu GD, Cunneen S, Cajulis E, Zajac I, et al.

Transplant Proc. 1993 Jun;25(3 Suppl 2):48-53. No abstract available.

PMID:
8516944
Items per page

Supplemental Content

Write to the Help Desk